Efficacy of MEK inhibition in a K-Ras-driven cholangiocarcinoma preclinical model.
Dong M, Liu X, Evert K, Utpatel K, Peters M, Zhang S, Xu Z, Che L, Cigliano A, Ribback S, Dombrowski F, Cossu A, Gordan J, Calvisi DF, Evert M, Liu Y, Chen X.
Dong M, et al. Among authors: peters m.
Cell Death Dis. 2018 Jan 18;9(2):31. doi: 10.1038/s41419-017-0183-4.
Cell Death Dis. 2018.
PMID: 29348467
Free PMC article.